Archives breast-cancer

by in
Entry Author Date Location
Sanofi Buys Genzyme for $20B, Aveo Inks Deal with Astellas, Hologix Nabs FDA Approval, & More Boston-Area Life Sciences News 02/18/11 Boston
Aveo Pharma Lands $1.4B Deal with Astellas, A Few Months Ahead of Cancer Trial Result 02/16/11 Boston
Genomic Health, Taking a Hit on Bottom Line, Bets Next-Gen Sequencing Will Yield Next-Gen Diagnostics 02/15/11 San Francisco
Hologic Gets FDA Nod for 3-D Mammography 02/14/11 Boston
Adriana Jenkins, Boston Biotech PR Maven, Dies from Breast Cancer at 41 02/10/11 Boston
NanoString, Snapping Up Genomic Health Veteran, Seeks to Prove Economic Value of Cancer Diagnostic 02/03/11 Seattle
FDA To Yank Avastin Breast Cancer Approval 12/16/10 San Francisco
Genomic Health Seeks to Build Momentum For Healthcare Shift from Rx to Dx 11/08/10 San Francisco
PacBio IPO, Not Exactly the Netscape Moment of 2010, But a Win for Genomics 10/28/10 San Francisco
Genentech’s Souped-Up Breast Cancer Drug Beats Original Herceptin in Head-to-Head Study 10/08/10 San Francisco
Cerulean Pharma Makes Progress in Attacking the Big C with Tiny Drugs 09/07/10 Boston
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA 08/27/10 Boston
Biocept Targets Spreading Tumors With Advance in Diagnostics 08/20/10 San Diego
Syndax Pharma Snags $6M Debt Deal 08/09/10 Boston
Genentech Fails to Sway FDA Panel 07/20/10 San Francisco
Corey Goodman’s New Startup, UCSF Spinoff Raises $40M, Gail Maderis Gives Back, & More Bay Area Life Sciences News 07/09/10 San Francisco
Genentech Seeks FDA Nod for T-DM1 07/07/10 San Francisco
On-Q-ity, Led by Former Genzyme Exec, Takes on “Diagnostic Black Hole” in Cancer 07/07/10 Boston
Tesaro: Former MedImmune CEO’s Firm Writes Check, Cancer Drug Vets Build Pipeline 06/28/10 Boston
Genentech’s Souped-Up Antibody, Reg Kelly’s Mission, LS9 Nears Moment of Truth & More Bay Area Life Sciences News 06/25/10 San Francisco
Genentech’s Souped-Up Herceptin: The Odyssey Toward a More Powerful Breast Cancer Drug 06/14/10 San Francisco
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News 06/11/10 Boston
Syndax’s Breast Cancer Drug Advances, Arena Raises Equity Financing, BeneChill Recruits a CEO, & More San Diego Life Sciences News 06/10/10 San Diego
Syndax Pharma Seeks to Reprogram Tumor Cells to Treat Breast Cancer 06/08/10 Boston
All-Michigan VC Team Helps Bring State-Grown Medical Imaging Technology to Market 06/03/10 Detroit Ann Arbor
Detroit Breast Cancer Imaging Company Delphinus Medical Gets $8M Investment 05/25/10 Detroit Ann Arbor
Who Needs VCs? Steven Quay’s Atossa Genetics Seeks Fast IPO For Breast Cancer Test 05/21/10 Seattle
Aragon Pharmaceuticals Moves to First Clinical Trial with $22M 04/22/10 San Diego
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes 04/14/10 Boston
West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News 03/11/10 San Diego
Page 3 of 4 « previous page · next page »